Another molecular marker identified for glioblastoma was KMT5B. It serves as a risk gene for autism spectrum disorder and has only been reported in pediatric glioma and diffuse intrinsic pontine glioma. The gene discussed is KMT5B; the disease is central nervous system cancer.